Supernus Pharmaceuticals (SUPN) Acquisitions (2020)
Supernus Pharmaceuticals' (SUPN) quarterly Acquisitions came in at $1.3 million in Q4 2020, down 99.55% on a QoQ basis from $297.2 million in Q2 2020.
Supernus Pharmaceuticals (SUPN) Acquisitions (2020) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 1 years of Acquisitions data on file, last reported at $1.3 million in Q4 2020.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $1.3 million in Q4 2020; TTM through Sep 2022 was $1.3 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $293.1 million, changed N/A from the prior year.
- Acquisitions for Q4 2020 stood at $1.3 million, down from $297.2 million in the prior quarter.
- Over the last five years, Acquisitions for SUPN reached as high as $297.2 million in Q2 2020 and fell as low as $1.3 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.34 Mn |
| Jun 9, 2020 | 297.20 Mn |